JP2005518412A - 内因性エストロゲンの合成を阻害する薬物の投与に伴う愁訴の治療におけるチボロン - Google Patents

内因性エストロゲンの合成を阻害する薬物の投与に伴う愁訴の治療におけるチボロン Download PDF

Info

Publication number
JP2005518412A
JP2005518412A JP2003561609A JP2003561609A JP2005518412A JP 2005518412 A JP2005518412 A JP 2005518412A JP 2003561609 A JP2003561609 A JP 2003561609A JP 2003561609 A JP2003561609 A JP 2003561609A JP 2005518412 A JP2005518412 A JP 2005518412A
Authority
JP
Japan
Prior art keywords
estrogen
tibolone
synthesis
treatment
complaints
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003561609A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518412A5 (enExample
Inventor
クローステルブール，ヘレニウス・ヤン
バンドレツド，ナイジエル
Original Assignee
アクゾ・ノベル・エヌ・ベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アクゾ・ノベル・エヌ・ベー filed Critical アクゾ・ノベル・エヌ・ベー
Publication of JP2005518412A publication Critical patent/JP2005518412A/ja
Publication of JP2005518412A5 publication Critical patent/JP2005518412A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
JP2003561609A 2002-01-22 2003-01-16 内因性エストロゲンの合成を阻害する薬物の投与に伴う愁訴の治療におけるチボロン Pending JP2005518412A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075235 2002-01-22
PCT/EP2003/000373 WO2003061665A1 (en) 2002-01-22 2003-01-16 Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen

Publications (2)

Publication Number Publication Date
JP2005518412A true JP2005518412A (ja) 2005-06-23
JP2005518412A5 JP2005518412A5 (enExample) 2006-03-16

Family

ID=27589110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003561609A Pending JP2005518412A (ja) 2002-01-22 2003-01-16 内因性エストロゲンの合成を阻害する薬物の投与に伴う愁訴の治療におけるチボロン

Country Status (16)

Country Link
US (1) US20050124592A1 (enExample)
EP (1) EP1469861A1 (enExample)
JP (1) JP2005518412A (enExample)
KR (1) KR20040073572A (enExample)
CN (1) CN1620298A (enExample)
BR (1) BR0306789A (enExample)
CA (1) CA2472240A1 (enExample)
EC (1) ECSP045179A (enExample)
HR (1) HRP20040635A2 (enExample)
IL (1) IL162769A0 (enExample)
IS (1) IS7338A (enExample)
MX (1) MXPA04007071A (enExample)
PL (1) PL371181A1 (enExample)
RU (1) RU2004125594A (enExample)
WO (1) WO2003061665A1 (enExample)
ZA (1) ZA200405262B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
AU671706B2 (en) * 1993-03-05 1996-09-05 Akzo N.V. Use of a Pregnane Derivative
JP2002522425A (ja) * 1998-08-07 2002-07-23 カイロン コーポレイション エストロゲンレセプターモジュレーターとしての置換イソオキサゾール

Also Published As

Publication number Publication date
RU2004125594A (ru) 2005-03-10
IS7338A (is) 2004-06-28
IL162769A0 (en) 2005-11-20
CN1620298A (zh) 2005-05-25
WO2003061665A1 (en) 2003-07-31
EP1469861A1 (en) 2004-10-27
US20050124592A1 (en) 2005-06-09
BR0306789A (pt) 2004-12-28
CA2472240A1 (en) 2003-07-31
ECSP045179A (es) 2004-08-27
ZA200405262B (en) 2005-08-31
PL371181A1 (en) 2005-06-13
KR20040073572A (ko) 2004-08-19
HRP20040635A2 (en) 2004-10-31
MXPA04007071A (es) 2004-10-29

Similar Documents

Publication Publication Date Title
US7683047B2 (en) Treatment of conditions relating to hormone deficiencies by administration of progestins
BG61798B1 (bg) Метод и фармацевтичен състав за лечение на простатнахиперплазия на база 5 алфа-редуктазен инхибитор
WO2007144152A2 (en) Extended step-down estrogen regimen
CA2581927C (en) Treatment or prevention of unscheduled bleeding in women on progestogen containing medication
US20050222100A1 (en) Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm
US6869941B2 (en) Combination of drospirenone and an estrogen sulphamate for HRT
TWI354556B (en) Use of a combination of an aromatase inhibitor,a p
WO2001049294A1 (en) Product for treating gynecomastia
JP2005518412A (ja) 内因性エストロゲンの合成を阻害する薬物の投与に伴う愁訴の治療におけるチボロン
AU2003236806A1 (en) Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen
US20100292150A1 (en) Treatment of Menorrhagia with Aromatase Inhibitor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060112

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090901

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100209